Titre:
  • Low-dose clofarabine in combination with a standard remission induction in patients aged 18-60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: Combined phase I/II results of the EORTC/GIMEMA AML-14A trial
Auteur:Selleslag, Dominik; Vignetti, Marco; Marie, Jean Pierre; Wittnebel, Sebastian; De Witte, Theo; Amadori, Sergio; Willemze, Roel; Baron, Frédéric; Suciu, Stefan; Meloni, Giovanna; Muus, Petra; Halkes, Constantijn J M; Venditti, Adriano; Ramadan, Safaa Mahmoud; Pruijt, Hans; Meert, Liv
Informations sur la publication:Haematologica, 102, 2, page (e47-e51)
Statut de publication:Publié, 2017
Sujet CREF:Généralités
Note générale:SCOPUS: le.j
Langue:Anglais
Identificateurs:urn:issn:0390-6078
info:doi/10.3324/haematol.2016.153130
info:scp/85011573612